当前位置:公众访问 >页面
简体中文 / English
1.Screening
1.1.Inclusion Criteria

Eligible participant has to fullfill all of the following items

/
/
/
/
/
/
/

1.2.Exclusion Criteria

Anyone with one of following items or more should be excluded:

/
/
/
/
/
/
/
/
/
/

2.Baseline
2.1.General information

Date of signing the informed consent

2024-2-8

Date of birth

1982-2-23 yyyy-mm-dd

Age

41 Years

Education background

Middle school

Occupation

Famer

Other (Description)

--

2.2.Medical history

10 小时

Number of pregnancy

5

Number of delivery

1

If has delivery history, select following items

partus maturus

1

premature delivery

0

abortion

4

Last pregnancy

不详 yyyy-mm-dd

Average times of menstrual onset a year

12 次/年

Average menstrual cycle

4 天(days)

Menarche time

15 岁(years)

The time of last Menstruation

2024-1-12 年、月、日(yyyy-mm-dd)

The time of menstrual onset before the last one

不详 年、月、日(yyyy-mm-dd)

小三阳 剖宫产

14年前小三阳、 年/月/日(yyyy-mm-dd)

Namy of the drug to be allergied

2.3.Physical examination

Vulva

Normal

Description in detail for abnormal

--

Vagina

Not examined

Description in detail for abnormal

可见暗红色血迹

Uterine neck

Normal

Description in detail for abnormal

--

Corpus uteri

Abnormal

Description in detail for abnormal

偏右侧

Adnexa uteri

Left side

Abnormal

Description in detail for abnormal

10*8*8cm包块,压痛。

Right side

Normal

Description in detail for abnormal

--

Weight

65 kg

Hight

1600 mm

Systolic pressure (SP)

160 mmHg

Diastolic pressure

98 mmHg

Temperature

36.4 degree Celsius

Pulse rate

66 次/分

Breath frequency

17 次/分

Doctor signature

刘义彬

Date

2024-2-8 yyyy-mm-dd

2.4.Blood Routine Tests

WBC

9.5 ×109 /L

NEUT%

88.16 %

LY%

8.59 %

RBC

4.37 ×10^12 /L

MONO%

2.92

HGB

137 g/L

PLT

287 ×10^9 /L

Researcher signature

刘义彬

Date

2024-2-8 yyyy-mm-dd

2.5.Urine Routine Test

Acidity and allkalinity

pH value

--

Urine protein

Urine red cell

Urine WBC

Urine glucos

Urine Bilirubin

Urine HCG

KET

SG

--

UBG

NIT

Date of test

未查 yyyy-mm-dd

2.6.Blood Electrolytes Tests

Date of test

2024-2-8 yyyy-mm-dd

K

未查 mmol/L

Na

-- mmol/L

Cl

-- mmol/L

Ca

-- mmol/L

P

-- mmol/L

2.7.Coagulation Function Tests

Date of examination

2024-2-8 yyyy-mm-dd

Prothrombin time

11.4

Thrombin time (TT)

13.7

Activated partial thromboplastin time (APTT)

28.4

Fibrinogen (FIB)

3.23 g/L

2.8.Serum Liver Function Tests

ALT

21.9 IU/L

AST

22.0 IU/L

GGT

13.0 U/L

Serum bilirubin

16.60 μmol/L

Indirect bilirubin

12.80 umol/L

Direct bilirubin

3.80 umol/L

Serum albumin

45.8 g/L

Serum globulin

32.5 g/L

Serum total protein

78.3 g/L

Date of test

2024-2-8 yyyy-mm-dd

2.9.HBV/HCV/HIV/Syphilis Markers Test
2.2.9.2.9.1、HBV Markers Test

Positive

Date of test

2024-2-8 yyyy-mm-dd

2.2.9.2.9.2、HCV Marker Test

Negative

Date of test

2024-2-8 yyyy-mm-dd

2.2.9.2.9.3、HIV Marker Test

Negative

Date of test

2024-2-8 yyyy-mm-dd

2.2.9.2.9.4、Syphilis Marker Test

Negative

Date of test

2024-2-8 yyyy-mm-dd

2.10.Renel Function Test

SCr

59.0 μmol/L

Blood urea

3.80 mmol/L

Blood uric acid

214.0 μmol/L

Date of test

2024-2-8 yyyy-mm-dd

2.11.D-dimer

D-dimer value

0.09 ug/mL

Date of test

2024-2-8

2.12.hCG Test

Urine pregnancy test

Not tested

Blood HCG concentration

-- mIU/mL

Date of test

2024-2-8 yyyy-mm-dd

2.13.Image Examinations
2.2.13.2.13.1、Ultrasound

Size of the ulcer

3.8*3.96*3.78 cm*cm

Uterine echo distribution

Even

Endometrial thickness

0.45 mm

Left ovary size

未描述 cm ×cm

Shape of Left ovary

Size of the Ovarian cyst

子宫后方12.86*9.59*7.2cm,混合性包块,内为强回声,部分为暗区,有的暗区内见短条状强回声

Right ovary size

未描述 cm ×cm

Shape of right ovary

Size of Ovarian cyst

--

Description of other abnormal findings

--

Diagnosis of the Ultrasound B

卵巢肿物

Doctor signature

刘义彬

Date of examination

2024-2-8 yyyy-mm-dd

2.2.13.2.13.2、Other examination
2.14.Visual Analogue Scale

Pain Visual Analogue Score

Very pain

2.15.Blood Gas Analysis

SO2

95.4

P02

82.6 mmHg

PCO2

36.0 mmHg

PH

7.385

Date of examination

2024-2-8 (yyyy-mm-dd)

LAC

1.77 mmol/L

SBE

-3.4 mmol/l

HCO3

21.6 mmol/l

3.In the process of the treatment
3.1.Treatment Record

左侧附件

12*10*8 cm

逆时针540度 °

/

刘义彬

2024-2-8

4.Follow-up
4.1.D-dimer

D-dimer value

0.56 ug/mL

Date of test

2024-2-9

4.2.Physical examination

Body temperature

36.8

Systolic pressure (SP)

未查 mmHg

Diastolic pressure (DP)

未查 mmHg

Heart Rate, HR

82 次/分

Pulse

82 次/秒

4.3.Blood Routine Tests

WBC

7.3 ×109 /L

NEUT%

62.81 %

LY%

25.92 %

RBC

3.71 ×10^12 /L

MONO%

10.33

HGB

121 g/L

PLT

241 ×10^9 /L

Date

20234-2-9 yyyy-mm-dd

4.4.Visual Analogue Scale

/

Pain Visual Analogue Score

Occasionally very slight pain

5.Speciman management system

sample collection

Volume

ml

Time of collection

yyyy-mm-dd-hh-min.

Label Number of the sample

6.ADR/ADE management system

Date received at DCC

yyyymmdd

Report type

Name of this event

SAE start date

yyyymmdd

SAE stop date

yyyymmdd

Was this an unanticipated adverse event

Attribution to Study Drug

Outcome Type(check all that apply)

Recovery Description: (check only one)

Please provide a brief narrative of the SAE occurrence below

Name of the recorder

Data

yyyymmdd

Site Investigator’s signature

Data

yyyymmdd